Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
2.070
-0.080 (-3.72%)
Aug 14, 2025, 2:12 PM - Market open
Ensysce Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 2.21 | 3.5 | 1.12 | 3.15 | 12.26 | 0.19 | Upgrade
|
| Cash & Short-Term Investments | 2.21 | 3.5 | 1.12 | 3.15 | 12.26 | 0.19 | Upgrade
|
| Cash Growth | 111.99% | 211.68% | -64.30% | -74.33% | 6215.06% | -43.13% | Upgrade
|
| Receivables | 1.2 | 0.12 | 0.1 | 0.28 | 0.44 | - | Upgrade
|
| Prepaid Expenses | 1.87 | 0.36 | 0.51 | 0.55 | 0.81 | 0.02 | Upgrade
|
| Other Current Assets | - | 1.36 | 0.55 | 1.33 | 2.15 | 0.14 | Upgrade
|
| Total Current Assets | 5.28 | 5.34 | 2.29 | 5.3 | 15.66 | 0.35 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | - | 0 | Upgrade
|
| Other Long-Term Assets | 0.29 | 0.25 | 0.42 | 0.59 | 0.75 | 0 | Upgrade
|
| Total Assets | 5.57 | 5.6 | 2.71 | 5.89 | 16.42 | 0.35 | Upgrade
|
| Accounts Payable | 1.04 | 1.36 | 1.94 | 2.94 | 0.3 | 1.72 | Upgrade
|
| Accrued Expenses | 1.05 | 0.55 | 0.54 | 2.23 | 3.41 | 0.19 | Upgrade
|
| Short-Term Debt | 0.42 | 0.3 | 0.85 | 4.27 | - | 4.25 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 12.75 | - | Upgrade
|
| Current Portion of Leases | - | - | - | 0.03 | 0.02 | 0.03 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | - | 0.16 | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 0.67 | Upgrade
|
| Total Current Liabilities | 2.51 | 2.21 | 3.33 | 9.46 | 16.48 | 7.01 | Upgrade
|
| Long-Term Debt | - | - | - | 0.14 | 4.44 | - | Upgrade
|
| Other Long-Term Liabilities | 0 | 0.01 | 0.03 | 0.31 | 3.65 | - | Upgrade
|
| Total Liabilities | 2.51 | 2.22 | 3.36 | 9.91 | 24.58 | 7.01 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 136.61 | 133.25 | 121.23 | 107.22 | 77.97 | 49.52 | Upgrade
|
| Retained Earnings | -133.22 | -129.54 | -121.56 | -110.93 | -85.85 | -55.96 | Upgrade
|
| Total Common Equity | 3.39 | 3.71 | -0.32 | -3.71 | -7.88 | -6.44 | Upgrade
|
| Minority Interest | -0.33 | -0.33 | -0.33 | -0.32 | -0.28 | -0.22 | Upgrade
|
| Shareholders' Equity | 3.06 | 3.38 | -0.65 | -4.03 | -8.16 | -6.66 | Upgrade
|
| Total Liabilities & Equity | 5.57 | 5.6 | 2.71 | 5.89 | 16.42 | 0.35 | Upgrade
|
| Total Debt | 0.42 | 0.3 | 0.85 | 4.43 | 17.21 | 4.27 | Upgrade
|
| Net Cash (Debt) | 1.79 | 3.2 | 0.27 | -1.29 | -4.95 | -4.08 | Upgrade
|
| Net Cash Growth | 203.52% | 1090.16% | - | - | - | - | Upgrade
|
| Net Cash Per Share | 1.33 | 4.59 | 1.78 | -107.24 | - | - | Upgrade
|
| Filing Date Shares Outstanding | 2.97 | 1.41 | 0.49 | 0.09 | 0.02 | 239.47 | Upgrade
|
| Total Common Shares Outstanding | 2.39 | 1.36 | 0.21 | 0.04 | - | 239.47 | Upgrade
|
| Working Capital | 2.77 | 3.14 | -1.04 | -4.17 | -0.82 | -6.66 | Upgrade
|
| Book Value Per Share | 1.42 | 2.74 | -1.54 | -104.24 | - | -0.03 | Upgrade
|
| Tangible Book Value | 3.39 | 3.71 | -0.32 | -3.71 | -7.88 | -6.44 | Upgrade
|
| Tangible Book Value Per Share | 1.42 | 2.74 | -1.54 | -104.24 | - | -0.03 | Upgrade
|
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.